Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion type Assertion NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_head.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion evidence source_evidence_literature NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion SIO_000772 23938603 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion wasDerivedFrom befree-20140225 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.
- NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_assertion wasGeneratedBy ECO_0000203 NP566539.RAXlNsstHGHoVkNFc2E5uz4VOJ0q6S9spMdn8OStxTzGE130_provenance.